Combination Pharmacotherapy for Methamphetamine Dependence: Extended Release Depot Naltrexone + Bupropion vs. Matched Placebos (ADAPT-MD)
This study will investigate the safety and efficacy of a combination pharmacotherapy – extended-release depot naltrexone plus extended-release bupropion for the treatment of methamphetamine dependence. The double-blind, placebo-controlled study includes random assignment of methamphetamine-dependent participants to one of two conditions: active medication or placebo for 8 weeks of pharmacotherapy provided with weekly psychosocial treatment.
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.
Formed with SAMHSA to reduce the gap between research results and treatment.